Evolution of anti-HIV drug candidates. Part 3: diarylpyrimidine (DAPY) analogues
作者:Donald W. Ludovici、Bart L. De Corte、Michael J. Kukla、Hong Ye、Chih Y. Ho、Mark A. Lichtenstein、Robert W. Kavash、Koen Andries、Marie-Pierre de Béthune、Hilde Azijn、Rudi Pauwels、Paul J. Lewi、Jan Heeres、Lucien M.H. Koymans、Marc R. de Jonge、Koen J.A. Van Aken、Frederik F.D. Daeyaert、Kalyan Das、Edward Arnold、Paul A.J. Janssen
DOI:10.1016/s0960-894x(01)00412-7
日期:2001.9
The synthesis and anti-HIV-1 activity of a series of diarylpyrimidines (DAPYs) are described. Several members of this novel class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) are extremely potent against both wild-type and a panel of clinically significant single- and double-mutant strains of HIV-1.
描述了一系列二芳基嘧啶(DAPYs)的合成和抗HIV-1活性。这种新型的非核苷类逆转录酶抑制剂(NNRTIs)的几个成员对野生型以及一组具有临床意义的HIV-1单突变和双突变菌株均具有极强的抵抗力。